Leveraging COVID-era Innovation for Cervical Cancer Screening: Clinician Awareness and Attitudes Toward Self-Sampling and Rapid Testing for HPV Detection

Development and Validation of a Novel TNM Staging N-Classification of Oral Cavity Squamous Cell Carcinoma

Utilizing Biomarkers to Optimize Treatment for Upper Gastrointestinal Cancers

Survival Benefit With Checkpoint Inhibitors Versus Chemotherapy is Modified by Brain Metastases in Patients With Recurrent Small-Cell Lung Cancer

Evaluating Strategies and Approaches to Prevent Graft-Versus-Host Disease

ChatGPT's Limited Ability to Recommend Guideline-Based Cancer Treatments

Response Assessment of Post-Treatment Head and Neck Cancers to Determine Further Management Using NI-RADS (Neck Imaging Reporting and Data System): A Subgroup Analysis of a Randomized Controlled Trial

IDEAYA Biosciences Receives Fast Track Designation for IDE161 in a Second Indication for the Treatment of Pretreated, Advanced or Metastatic HR+, HER2-, BRCA1/2 Mutant Breast Cancer

Leveraging COVID-era Innovation for Cervical Cancer Screening: Clinician Awareness and Attitudes Toward Self-Sampling and Rapid Testing for HPV Detection

header-info

Mar, 13, 2023

Researchers explore clinician perspectives on HPV self-testing developed during the COVID-19 pandemic. Findings highlighted an increased willingness for clinicians to adopt rapid testing but adequacy concerns still exist.

Access the full article to read more here.